171 related articles for article (PubMed ID: 7682239)
1. Requirement for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody.
Ruff-Jamison S; Glenney JR
J Immunol; 1993 Apr; 150(8 Pt 1):3389-96. PubMed ID: 7682239
[TBL] [Abstract][Full Text] [Related]
2. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
[TBL] [Abstract][Full Text] [Related]
3. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
Ruff-Jamison S; Glenney JR
Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
[TBL] [Abstract][Full Text] [Related]
5. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
Polymenis M; Stollar BD
J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
[TBL] [Abstract][Full Text] [Related]
6. Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.
de Kruif J; Kramer A; Visser T; Clements C; Nijhuis R; Cox F; van der Zande V; Smit R; Pinto D; Throsby M; Logtenberg T
J Mol Biol; 2009 Apr; 387(3):548-58. PubMed ID: 19361421
[TBL] [Abstract][Full Text] [Related]
7. VH and VL gene usage by murine IgG antibodies that bind autologous insulin.
Ewulonu UK; Nell LJ; Thomas JW
J Immunol; 1990 Apr; 144(8):3091-8. PubMed ID: 2109009
[TBL] [Abstract][Full Text] [Related]
8. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
[TBL] [Abstract][Full Text] [Related]
9. The amino acid residues at the VH-D-JH junctions affect the affinity of anti-p-azophenylarsonate antibodies.
Parhami-Seren B; Wysocki L; Margolies MN
J Immunol; 1989 Dec; 143(12):4090-7. PubMed ID: 2512349
[TBL] [Abstract][Full Text] [Related]
10. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
11. Influence of VH CDR3 arginine and light chain pairing on DNA reactivity of a bacterial DNA-induced anti-DNA antibody from a BALB/c mouse.
Wloch MK; Clarke SH; Gilkeson GS
J Immunol; 1997 Dec; 159(12):6083-90. PubMed ID: 9550408
[TBL] [Abstract][Full Text] [Related]
12. The immune response toward beta-adrenergic ligands and their receptors. VIII. Extensive diversity of VH and VL genes encoding anti-alprenolol antibodies.
Nahmias C; Strosberg AD; Emorine LJ
J Immunol; 1988 Feb; 140(4):1304-11. PubMed ID: 3125254
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid factor autoantibody-binding site: a molecular analysis using monoclonal antibodies with dual anti-TNP and anti-IgG activities.
Reininger L; Spertini F; Shibata T; Jaton JC; Izui S
Eur J Immunol; 1989 Nov; 19(11):2123-30. PubMed ID: 2513210
[TBL] [Abstract][Full Text] [Related]
14. Lack of promiscuity in autoantigen-specific H and L chain combinations as revealed by human H and L chain "roulette".
Portolano S; Chazenbalk GD; Hutchison JS; McLachlan SM; Rapoport B
J Immunol; 1993 Feb; 150(3):880-7. PubMed ID: 8423344
[TBL] [Abstract][Full Text] [Related]
15. Relative noncovalent association constant between immunoglobulin H and L chains is unrelated to their expression or antigen-binding activity.
Hamel PA; Klein MH; Smith-Gill SJ; Dorrington KJ
J Immunol; 1987 Nov; 139(9):3012-20. PubMed ID: 3117886
[TBL] [Abstract][Full Text] [Related]
16. V region sequences of anti-DNA and anti-RNA autoantibodies from NZB/NZW F1 mice.
Eilat D; Webster DM; Rees AR
J Immunol; 1988 Sep; 141(5):1745-53. PubMed ID: 2457627
[TBL] [Abstract][Full Text] [Related]
17. Diversity in the available repertoire of murine antibodies reactive with bromelain-treated isologous erythrocytes.
Conger JD; Sage HJ; Corley RB
J Immunol; 1989 Dec; 143(12):4044-52. PubMed ID: 2512347
[TBL] [Abstract][Full Text] [Related]
18. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
Polymenis M; Stollar BD
J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
[TBL] [Abstract][Full Text] [Related]
19. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors.
Crouzier R; Martin T; Pasquali JL
J Immunol; 1995 May; 154(9):4526-35. PubMed ID: 7722307
[TBL] [Abstract][Full Text] [Related]
20. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
